MDM2-mediated ubiquitination of IGF-1R with PPP treatment leads to the activation of ERK pathway [37], resulting in the resistance of Ewing’s sarcoma to the treatment of the anti-IGF-1R antibody figitumuab [38]. Here, IGF1R is linked to Ewing sarcoma.